The Sydney Morning Herald says that researchers at the University of NSW have developed a new class of drug, made from DNA enzymes, which acts on the DNA in the cells of veins to permanently switch off the urge to reject.
The drug, known as DNAzyme, has only been used on rabbits but clinical trials are expected to start in April and researchers are confident the drug will change the face of cardiac surgery, the report says.
|
